SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 101,500
-3,700 (-3.52%)
At close: Sep 26, 2025
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 7.95 trillion as of September 26, 2025. Its market cap has decreased by -10.34% in one year.
Market Cap
7.95T
Enterprise Value
7.82T
Revenue
620.28B
Ranking
n/a
PE Ratio
31.05
Stock Price
101,500.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.95T, a decrease of -20.08%. That is a compound annual growth rate of -4.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2025 | 8,238.55B | -5.31% |
| Dec 30, 2024 | 8,700.60B | 10.66% |
| Dec 28, 2023 | 7,862.65B | 39.25% |
| Dec 29, 2022 | 5,646.39B | -25.82% |
| Dec 30, 2021 | 7,612.05B | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.17T |
| Celltrion | 39.21T |
| ALTEOGEN | 23.89T |
| Yuhan | 8,582.33B |
| Peptron | 6,470.56B |
| PharmaResearch | 5,683.14B |
| LigaChem Biosciences | 5,185.05B |
| ABL Bio | 5,091.86B |